Question 1

What Is the Dexcom G7 Class Action Lawsuit About?

Accepted Answer

Wilshire Law Firm is pursuing legal action against Dexcom, Inc. over allegations that it falsely advertised the G7 Continuous Glucose Monitor as "the most accurate CGM system available." On March 4, 2025, the FDA issued a Warning Letter citing manufacturing problems, unapproved design changes to the sensor coating, and insufficient risk analysis — leading the agency to determine the devices were misbranded and adulterated.

Question 2

What Did the FDA Warning Letter Find?

Accepted Answer

According to the FDA Warning Letter, Dexcom's G7 had several serious issues: inadequate monitoring and validation during production, a major change to the sensor coating made without proper FDA clearance, and a lack of proper safety assessment for use with automated insulin dosing systems. The lawsuit alleges these problems contradicted Dexcom's accuracy claims, especially during rapid changes in glucose levels.

Question 3

Who Is Eligible to Join the Dexcom Class Action?

Accepted Answer

You may be eligible if you purchased a Dexcom G7 after December 13, 2023 and live in one of the following: Washington D.C., Pennsylvania, California, New York, New Jersey, Massachusetts, Washington, Illinois, Florida, Oregon, or New Mexico. Proof of purchase is required. A legal professional can confirm whether you qualify during a free case review.

Question 4

What is the Dexcom G7 class action about?

Accepted Answer

The case involves allegations that Dexcom marketed its G7 continuous glucose monitor as more accurate than it actually was, and it points to a U.S. Food and Drug Administration warning letter that cited manufacturing and quality concerns. The lawsuit seeks to hold the company accountable to consumers who purchased the device based on those accuracy claims. These are allegations, and the facts would be tested through the legal process.

Question 5

Who may be eligible to take part in the Dexcom G7 class action?

Accepted Answer

Eligibility generally focuses on people who purchased a Dexcom G7 after a specific date and who live in one of the states currently included in the case. Because eligibility criteria can change as the litigation develops, the best way to know whether you qualify is to have your purchase and location reviewed. An attorney can confirm the current requirements.

Question 6

What kind of proof do I generally need?

Accepted Answer

In most product cases like this, you will generally need something showing that you purchased the device, such as a receipt, order confirmation, pharmacy record, or insurance statement. You do not need to have everything gathered before reaching out. An attorney can explain what documentation may support your participation.

Question 7

How does a false-advertising class action like this generally work?

Accepted Answer

A false-advertising class action combines the claims of many purchasers who allege they were misled about a product into a single case, which a court must certify before it can proceed on behalf of the group. If it succeeds, relief may include refunds or other compensation tied to the purchase. Because each person's individual losses may be modest, grouping the claims can make accountability practical.

Question 8

Is there a deadline to join or file?

Accepted Answer

Yes. Consumer and false-advertising claims carry statutes of limitations that can run from the purchase or from when the problem was discovered, and these windows can be shorter than people expect. Acting promptly helps protect your ability to take part. Because deadlines have exceptions, confirm the one that applies to you without delay.

Dexcom G7 Class Action Lawsuit

Understanding Your Consumer Case

Meet Our Consumer Attorneys

Client Reviews

Our recent wins

Consumer Cases: How It Works

Start Your Free Consumer Case Review

Winners of #1 Settlements in California

Consumer FAQs

Related Content

Esse Health data breach lawsuit